Adivir, Inc. /
Appili Therapeutics, Inc.
Adivir and Appili Therapeutics agree to an arrangement
What happened
Adivir, Inc. agreed to acquire all issued and outstanding Class A common shares of Appili Therapeutics, Inc. under an arrangement agreement with Aditxt, Inc.
The parties amended the agreement on Aug. 20, 2024, extending the outside date to Nov. 19, 2024. The arrangement remains subject to conditions, including completion of the continuance.
The source
Everything on this page comes from the source below.
Adivir and Appili Therapeutics agree to an arrangement
This document is the source for the companies, stage and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verifiedAgreement signed
The source this page is built from.
Source-verifiedAlso stated
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly